title: Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.
authors.affiliation: Headache Group, Institute of Neurology, Queen Square, London, United Kingdom.
authors.forename: Manjit S
authors.initials: MS
authors.lastname: Matharu
authors.forename: Miles J
authors.initials: MJ
authors.lastname: Levy
authors.forename: Karim
authors.initials: K
authors.lastname: Meeran
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Goadsby
mesh_terms: D000293:Adolescent; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003027:Cluster Headache / Q000188:drug therapy*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010147:Pain Measurement; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide